Societal value of generic medicines beyond cost-saving through reduced prices.

  title={Societal value of generic medicines beyond cost-saving through reduced prices.},
  author={Pieter Dylst and Arnold Vulto and Steven Simoens},
  journal={Expert review of pharmacoeconomics & outcomes research},
  volume={15 4},
OBJECTIVE This paper aims to provide an overview of the added societal value of generic medicines beyond their cost-saving potential through reduced prices. In addition, an observational case study will document the impact of generic entry on access to pharmacotherapy in The Netherlands and an illustrative exercise was carried out to highlight the budget impact of generic entry. METHODS A narrative literature review was carried out to explore the impact of generic medicines on access to… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 2 times. VIEW TWEETS

From This Paper

Figures, tables, and topics from this paper.

Explore Further: Topics Discussed in This Paper


Publications referenced by this paper.
Showing 1-10 of 57 references

Generic medicines: essential contributors to the long-term health of society

A. Sheppard
Sector sustainability challenges in Europe; • 2010
View 6 Excerpts
Highly Influenced

Analysis of European policy towards generic medicines

P Dylst, A Vulto, S. Simoens
GaBi Journal • 2014
View 1 Excerpt

Het gaat fout met die steeds wisselende geneesmiddelen

T van Gelder, A. Vulto
NRC Handelsblad • 2014

Demand-side policies to encourage the use of generic medicines: an overview.

Expert review of pharmacoeconomics & outcomes research • 2013
View 1 Excerpt

Similar Papers

Loading similar papers…